Clinical trial

CKD-828 Telmisartan Non-Responder Trial

NCT01426100

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-08-01

PhasePHASE3

Study timeline

Study start (unknown)2011-08-01Date precision: month

Registry last updated2012-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

CKD-828 40/2.5mgDRUG

CKD-828 40/5mgDRUG

Telmisartan 80mgDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea9 DaeguSouth Korea2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01426100 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.